New SDCEP guidance launchedApril 5, 2017
New dental clinical guidance Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw was launched this week.
The guidance provides recommendations, advice and information to help dental practitioners manage the routine dental care of patients prescribed drugs associated with medication-related osteonecrosis of the jaw (MRONJ). This guidance is an update to the previous SDCEP Oral Health Management of Patients Prescribed Bisphosphonates guidance.
The guidance is aimed primarily at dentists, hygienists and therapists in primary care dental practice and will also be of relevance to the secondary care dental service, those involved in dental education and undergraduate trainees.
The new guidance comprises:
- The full Guidance document
- A summary Guidance in Brief
- Supporting tools including patient information leaflets
Forthcoming NES CPD events to support the publication of the new guidance
- A 3 hour NES CPD course covering the new guidance will take place on Wednesday 10th May 2017. Register via Portal